Genetic engineering of Lactococcus lactis to produce an amylase inhibitor for development of an anti-diabetes biodrug

New Microbiologica

Volumn 35, Issue 1, 2012, Pages 35-42

  D'Souza, Roshan ^a   Pandeya, Dipendra Raj ^a   Rahman, Mashiar ^a   Lee, Hyun Seo ^a   Jung, Jin Kyoung ^a   Hong, Seong Tshool ^a  

^a Chonbuk National University   (South Korea)

Author keywords

amylase inhibitors; Lactococcus lactis; Post prandial hyperglycemia

Indexed keywords

AMYLASE; ANTIDIABETIC AGENT; BIOLOGICAL PRODUCT; ENZYME INHIBITOR; GHWYYRCW PEPTIDE; OLIGOPEPTIDE; YOGHURT;

ANIMAL; ARTICLE; BACTERIUM TRANSFORMATION; C57BL MOUSE; DIET THERAPY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC ENGINEERING; GENETICS; GLUCOSE BLOOD LEVEL; LACTOCOCCUS LACTIS; MALE; METABOLISM; MICROBIOLOGY; MOLECULAR CLONING; MOUSE; TREATMENT OUTCOME;

AMYLASES; ANIMALS; BIOLOGICAL AGENTS; BLOOD GLUCOSE; CLONING, MOLECULAR; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC ENGINEERING; GENETIC VECTORS; HYPOGLYCEMIC AGENTS; LACTOCOCCUS LACTIS; MALE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; TRANSFORMATION, BACTERIAL; TREATMENT OUTCOME; YOGURT;

LACTOCOCCUS LACTIS; MUS;

EID: 84863132042     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ALEXANDER B., PATRICK W., STÉPHANE M., OLIVIER J. (2001). The complete genome sequence of the Lactic Acid Bacterium Lactococcus Lactis Ssp. Lactis IL1403. Genome Research. 11, 731-753.
2. AMOS A.F., MCCARTY D.J., ZIMMET P. (1997). The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 14, S7-S85. (Pubitemid 28020378)
3. BLANQUET S., MAROL-BONNIN S., BEYSSAC E., POMPON D., RENAUDM., ALRICM. (2001). The 'biodrug' con-cept: an innovative approach to therapy. Trends Biotechnol. 19, 393-400. (Pubitemid 32925032)
4. BREUER H.W. (2003). Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes. Int. J. Clin. Pharmacol. Ther. 43, 421-440.
5. CARLS E.B.C., JÚLIO C.V. (2009). Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetology & Metabolic Syndrome. 1, 1-5.
6. DAMAK S., BULLOCK D.W. (1993). A simple two step method for efficient blunt-end ligation of DNA fragments. Biotechniques. 15, 448-452. (Pubitemid 23270475)
7. DIEYE Y., USAI S., CLIER F. (2001). Design of a proteintargeting system for lactic acid bacteria. J. Bacteriol. 183 (14), 4157-4166. (Pubitemid 32568066)
8. DOLE KOVÁ-MAREŠOVÁ L., AAVLÍK M., HORN M., MAREŠ M. (2005). De Novo design of -amylase inhibitor: A small linear mimetic of macromolecular proteinaceous ligands. Chemistry & Biology. 277, 1349- 1357.
9. GIN H., RIGALLEAU V. (2000). Post-prandial hyperglycemia: postp randial hyperglycemia and diabetes. Diabetis. Diab. Metabol. 26, 265-272.
10. HARIOM Y., SHALINI J., SINHA P.R. (2006). The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Biosci. Biotechnol. Biochem. 70, 1255-1258.
11. HOKARI S., KAE M., IWAO K. (2003). Expression of ?- amylase isozymes in rat tissues. Comparitive biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 135 (1), 63-69. (Pubitemid 36627731)
12. JOANNE D., SUSAN J.F. (2002). Quantification of proteins on western blots using ECL. The protein protocols handbook, New Jersey. Humana Press Inc. 2nd edition, 429-437.
13. JOSÉE D., CLAUDIA L., INGA P., RICHA S., NICOLE S. (2010). Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risks. Nat Genet. 42, 106-116.
14. KAZUTAKA A., TOMONORI M., YUZURU I., YU T., YASUO T. (2010) Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study. Inter. Med. 49, 1085-1087.
15. KUMAR P.J., CLARK M. (2002). Diabetes mellitus and other disorders of metabolism. Clin. Med. 1069- 1152.
16. LANGELLA P., LE LOIR Y. S., EHRLICH D., GRUSS A. (1993). Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis. J. Bacteriol. 175, 5806-5813. (Pubitemid 23277427)
17. NOTKINS A.L. (2002). Immunologic and genetic factors in type 1 diabetes. Biol. Chem. 277, 43545-43548. (Pubitemid 36157765)
18. OCTÁVIO L.F., DANIEL R.J., FRANCISLETE R.M., MARIA F.G. (2002). Plant amylase inhibitors and their interaction with insect amylase. Eur. J. Biochem. 269, 397- 412.
19. PURNELL J.Q., HOKANSON J.E., MARCOVINA S.M., STEFFES M.W., CLEARY P.A., BRUNZELL J.D. (1998). Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial JAMA. 280, 140-146. (Pubitemid 28498385)
20. SAHOO N., CHOUDHURY K., MANCHIKANTI P. (2009). Manufacturing of biodrugs: need for harmonization in regulatory standards. Biodrugs. 23, 217-229.
21. SAMBROOK J., FRITSCH E. F., MANIATIS T. (1989). Molecular cloning: a laboratory manual, Cold Spring Harbor, New York: Cold Spring Harbor Lab.
22. SIBLEY S.D., PALMER J.P., HIRSCH I.B., BRUNZELL J.D. (2003). Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J. Clin. Endocrinol. Metab. 88, 3379-3384. (Pubitemid 36877520)
23. SMITH P.W. (1981) "Milk Pasteurization" Fact Sheet Number 57, U.S. Department of Agriculture Research Service, Washington. D.C.
24. TERZAGHI B.E., SANDINEW E. (1975). Improved medium for lactic streptococci and their bacteriophages. Appl. Environ. Microbiol. 29, 807-813.
25. THE DCCT RESEARCH GROUP. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
26. WU X.C., LEE W., TRAN L., WONG S.L. (1991). Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 173, 4952-4958.
27. ZIMMET P.Z. (1999). Diabetes epidemiology as a trigger to diabetes research. Diabetologia. 42, 499-518.
28. ZIMMET P.Z., ALBERTI K.G.M.M., SHAW J. (2001). Global and societal implications of the diabetes epidemic. 414, 782-787.